CA Patent

CA2744906A1 — Progesterone-containing compositions and devices

Assigned to Individual · Expires 2009-06-04 · 17y expired

What this patent protects

The present invention is directed to progesterone-containing compositions and devices that can maintain opening of a body passageway. One aspect of the invention provides a therapeutically effective (e.g., relaxative, anti-oxidative, anti-restenotic, anti-angiogenic, and/or anti …

USPTO Abstract

The present invention is directed to progesterone-containing compositions and devices that can maintain opening of a body passageway. One aspect of the invention provides a therapeutically effective (e.g., relaxative, anti-oxidative, anti-restenotic, anti-angiogenic, and/or anti -thrombotic) composition or formulation containing progesterone and optionally vitamin E. Another aspect of the invention provides a drug eluting device with at least one coating layer comprising a progesterone composition that can minimize or eliminate inflammation, thrombosis, restenosis, neo-intimal hyperplasia, rupturing of vulnerable plaque, and/or other effects related to device implantation, treatment, or interaction. Other aspects of the invention provide for methods of using such compositions, formulations, and devices.

Drugs covered by this patent

Patent Metadata

Patent number
CA2744906A1
Jurisdiction
CA
Classification
Expires
2009-06-04
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.